期刊文献+

粘多糖病的治疗和护理现状 被引量:5

原文传递
导出
摘要 总结国内外粘多糖病的治疗和护理现状。应用PubMed及CNKI全文数据库检索系统,以“粘多糖病、溶酶体贮积症、亨特综合征”等为检索词,检索2002-2013年的相关文献,共检索到英文文献513篇,中文文献65篇。文献纳入标准:粘多糖病的治疗方法;粘多糖病的护理方法;治疗药物和方法的并发症。符合纳入标准的文献35篇。骨髓移植和酶替代疗法是比较成熟的治疗方法,相应的护理经验丰富;基质减少疗法及基因治疗尚处于发展阶段。粘多糖病的治疗向着低成本,高安全性方向发展,对护理提出了新的挑战。
作者 周伟丽
出处 《中华现代护理杂志》 2014年第23期3004-3007,共4页 Chinese Journal of Modern Nursing
  • 相关文献

参考文献35

  • 1Bailey L. An Overview of Enzyme Replacement Therapy for Lysosomal Storage Diseases [ J ]. Online J Issues Nurs, 2008,13 ( 1 ) : Manuscript 3.
  • 2Muenzer J. Overview of the mueopolysaccharidoses [ J ]. Rheumatology (Oxford) ,2011,50( Suppl 5 ) :v4-v12.
  • 3Martin R, Beck M, Eng C, et al. Recognition and diagnosis of mucopolysaeeharidosis II (Hunter syndrome) [J]. Pediatrics, 2008,121 (2) :e377-e386.
  • 4Sifuentes M, Doreshow R, Hoft R, et al. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years[ J]. Mol Genet Metab,2007,90(2) : 171-180.
  • 5Valayannopoulos V, Wijburg FA. Therapy for the mucopolysaccharidoses [ J ]. Rheumatology ( Oxford ), 2011,50 ( Suppl 5 ) :49-59.
  • 6Whitley CB, James Utz JR. Maroteanx-Lamy syndrome (mucopolysaccharidosis type VI ) : A single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation[ J ]. Mol Genet Metab, 2010, 101 ( 4 ) : 346- 348.
  • 7Banecka-Majkutewiez Z, Jako' bkiewicz-Banecka J, Gabig- Cimifiska M,et al. Putative biological mechanisms of efficiency of substrate reduction therapies for mueopolysaecharidoses[ J]. Arch Immunol Ther Exp (Warsz) ,2012,60 (6) :461-468.
  • 8Kloska A ,Jak6bkiewiez-Baneeka J, Narajezyk IV[, et al. Effects of flavonoids on glycosaminoglycan synthesis : implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses [ J ]. Metab Brain Dis,2011,26 ( 1 ) : 1-8.
  • 9Arfi A, Richard M, Gandolphe C, et al. Storage correction in cells of patients suffering from mucopolysaecharidoses types IIIA and VII after treatment with genistein and other isoflavones [ J ]. J Inherit bletab Dis,2010,33( 1 ) :61-67.
  • 10Dziedzic D, Wegrzyn G, Jak6bkiewiez-Banecka J, et al. Impairment of glycosaminoglyean synthesis in mueopolysaccharidosis type IliA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease [ J ]. Eur J Hum Genet,2010,18 ( 2 ) :200-205.

二级参考文献143

共引文献36

同被引文献47

  • 1胡小燕,李卓燕,黄海英,李建斌,杨凡,唐思安,张小康.异基因造血干细胞移植治疗粘多糖病10例的护理体会[J].广东医学,2019,40(S01):289-290. 被引量:1
  • 2郭奕斌,杜传书.中国广东Hunter综合征患者的T1140C新突变[J].遗传,2006,28(5):521-524. 被引量:6
  • 3Am P, Bruce lA, Wraith lE. et al. Airway-related symptoms and surgeries in patients with mucopolysaccharidosis 1[1). Ann Otol Rhinol Laryngol, 2015,124:198-205.
  • 4Hendriksz Cl . Berger KI, Giugliani R, et aI. International guidelines for the management and treatment of Morquio A syndrome[l). Am 1 Med Genet A. 2015, 167A:11-25.
  • 5Muenzer 1. Overview of the mucopolysaccharidoses[J]. Rheumatology (Oxford), 2011, 50 SuppI5:v4-12.
  • 6Gtiniilda§ B, Yilmaz T, Sivri HS, et al. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway[J]. Int J Pediatr Otorhinolaryngol, 2014, 78:944-949.
  • 7Pelley CJ, Kwo J, Hess DR. Tracheomalacia in an adult with respiratory failure and Morquio syndrome[J]. Respir Care, 2007, 52: 278-282.
  • 8Mesolella M, Cimmino M, Cantone E, et al. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience[J]. Acta Otorhinolaryngol Ital, 2013, 33:267-272.
  • 9Jeong HS, Cho DY, Ahn KM. Complications of tracheotomy in patients with mucopolysaccharidoses type II (Huntersyndrome)[J]. Int J Pediatric Otorhinolaryngol, 2006, 70:1765-1769.
  • 10Walker RW, Colovic V, Robinson DN, et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses[J]. Paediatr Anaesth, 2003, 13:441-447.

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部